SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000886163-18-000071
Filing Date
2018-05-18
Accepted
2018-05-18 08:10:23
Documents
5
Period of Report
2018-05-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ligand-form8xkre2018noteso.htm 8-K 21073
2 EXHIBIT 99.1 projectlighthouse-pricingp.htm EX-99.1 18548
3 EXHIBIT 99.2 ligandannouncesproposedoff.htm EX-99.2 20304
4 ligandannouncespropos_image1.gif GRAPHIC 11576
5 projectlighthousepric_image1.gif GRAPHIC 2945
  Complete submission text file 0000886163-18-000071.txt   81360
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 18845086
SIC: 2834 Pharmaceutical Preparations